Biodefense Diplomacy Enhancement Act
- Bill Number
- H.R. 7653
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2026-03-26: Ordered to be Reported by the Yeas and Nays: 46 - 0.
- Last Updated
- 2026-07-01T08:08:38Z
AI-Generated Summary
Purpose of the Legislation
The Biodefense Diplomacy Enhancement Act (H.R. 7653) seeks to strengthen U.S. diplomatic efforts in international biodefense, biosecurity, and biotechnology. It directs the Department of State to promote cooperation with allies and partners to counter biological threats, enhance global standards for biological research safety, and improve coordinated responses to potential biological incidents, such as attacks or outbreaks.
Key Provisions
- Diplomatic Advancement: The Secretary of State must pursue U.S. foreign policy goals by fostering cooperation on biodefense (actions to counter biological threats and prepare for incidents), biosecurity (controls to prevent misuse of biological materials), and biotechnology (use of biological processes for research or medical purposes, including genetic engineering).
- NATO-Specific Efforts: In coordination with key State Department officials and the U.S. representative to NATO, the Secretary must:
- Advocate for prioritizing biodefense policies in NATO, covering areas like biotechnology, biosurveillance (early detection of biological threats), and countermeasures against biological hazards.
- Identify ways to strengthen NATO's planning and activities, including potential updates to its Chemical, Biological, Radiological, and Nuclear Defence Policy.
- Enhance NATO member states' capabilities in detection, response, and recovery from biological attacks.
- Promote high safety standards in biological research among NATO members and explore NATO's role in developing biotechnology for security purposes.
- Cooperation with Allies and Partners: The Secretary must engage with U.S. allies, including NATO countries and major non-NATO allies (countries designated for special security cooperation under U.S. law), by:
- Exploring joint work in biotechnology, biosecurity, and biodefense.
- Coordinating export controls on dual-use biotechnology items (technologies that could be used for peaceful or military purposes, like developing bioweapons).
- Encouraging adherence to safety standards in biological research.
- Collaborating on enforcing the Biological Weapons Convention (an international treaty banning biological weapons).
- Required Strategies:
- NATO Biodefense Strategy: Assesses current U.S.-NATO cooperation, identifies gaps in planning and capabilities (e.g., biosurveillance and countermeasures), and recommends solutions like joint development and coordination.
- International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy: Proposes agreements to expand cooperation, evaluates new export control mechanisms beyond existing groups like the Wassenaar Arrangement (a multilateral export control regime), and suggests uses for State Department funds (e.g., Nonproliferation, Antiterrorism, Demining, and Related Programs) to address biosecurity threats.
- Both strategies focus solely on threats from biological agents and toxins as defined in U.S. criminal law (18 U.S.C. § 178, referring to microbes or poisons that can harm humans, animals, or plants).
- Reporting and Oversight:
- A report containing both strategies must be submitted to Congress (specifically, the House Foreign Affairs Committee and Senate Foreign Relations Committee) within 270 days of enactment, in unclassified form with an optional classified annex.
- A briefing on the report and global biotechnology/biosecurity developments affecting U.S. security must occur within 90 days.
- Definitions: The bill provides clear definitions for terms like "biological threat" (hazards that could cause incidents) to ensure consistent application.
Significant Changes to Existing Law
This bill introduces new mandates for the Department of State to develop specific strategies and pursue enhanced diplomatic activities in biodefense and biotechnology, which were not previously required by statute. It builds on existing frameworks, such as NATO policies and the Biological Weapons Convention, by directing active U.S. leadership in revisions and implementations but does not amend prior laws directly. Instead, it adds reporting and coordination requirements to promote proactive international engagement.
Potential Impacts
- Government Agencies: The Department of State will face increased responsibilities for strategy development, interagency coordination (e.g., with arms control and political affairs offices), and diplomatic initiatives, potentially requiring additional resources. Other U.S. agencies involved in biodefense (e.g., those handling health or security) may see expanded collaboration.
- Citizens: Indirect benefits through improved U.S. and allied preparedness against biological threats, which could enhance national security and reduce risks from pandemics or attacks, though no direct effects on individual rights or daily life.
- International Relations: Strengthens U.S. ties with NATO and non-NATO allies by promoting joint capabilities and standards, potentially leading to better global enforcement of biosecurity norms and export controls. This could improve collective responses to biological risks but may strain relations if allies resist policy changes.
Main Stakeholders Affected
- U.S. Department of State: Primary implementer, including its Under Secretaries for Arms Control and Political Affairs.
- NATO and Member States: Directly involved in policy prioritization, capability enhancements, and strategy implementation.
- Major Non-NATO Allies (e.g., countries like Australia, Japan, or Israel, designated under the Foreign Assistance Act): Targeted for expanded cooperation on security and export controls.
- U.S. Congress: Receives reports and briefings, influencing oversight of foreign policy.
- Broader International Community: Benefits from enforced standards under the Biological Weapons Convention and potential new agreements.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes enforceable deadlines for strategies and reports, promoting accountability in foreign affairs without creating new regulatory burdens. Limits scope to defined biological threats, aligning with U.S. criminal definitions to avoid overreach.
- Constitutional: Operates within Congress's powers to regulate foreign commerce and declare war, and the executive's authority over diplomacy, by directing the President (via the Secretary of State) without infringing on treaty-making powers.
- Political: Positions the U.S. as a leader in global biosecurity amid rising concerns over biotechnology risks (e.g., synthetic biology misuse), potentially influencing multilateral forums like NATO. It emphasizes cooperation over confrontation, which could foster alliances but requires bipartisan support for funding and implementation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (6)
Rep. Keating, William R. [D-MA-9], Rep. Sherman, Brad [D-CA-32], Rep. Baird, James R. [R-IN-4], Rep. Lawler, Michael [R-NY-17], Rep. Lee, Susie [D-NV-3], Rep. Ross, Deborah K. [D-NC-2]
Recent Actions
- 2026-03-26: Ordered to be Reported by the Yeas and Nays: 46 - 0.
- 2026-03-26: Committee Consideration and Mark-up Session Held
- 2026-02-23: Referred to the House Committee on Foreign Affairs.
- 2026-02-23: Introduced in House
- 2026-02-23: Introduced in House
Bill Versions
- Biodefense Diplomacy Enhancement Act — issued 2026-02-23 — PDF (9 pages)